Osiris Therapeutics appoints Hunt as CFO
Stem cell therapeutic company Osiris Therapeutics Inc. (Nasdaq:OSIR) said before today’s opening that Richard W. Hunt had filled the chief financial officer spot effective July 23. The Columbia, Md.-based company also said it had promoted Philip R. Jacoby Jr. to vice president of finance.
In today’s trading, shares are mostly flat from Friday’s close of $15.46. Shares have ranged from $9.98 to $15.60.
For detailed price information and recent news stories about Osiris Therapeutics Inc., click OSIR.
